港股市场速览：市场有所回调，创新药持续走高

Investment Rating - The report maintains an "Outperform" rating for the Hong Kong stock market [4] Core Viewpoints - The market has experienced a pullback, with the Hang Seng Index down by 3.5% and the Hang Seng Technology Index down by 4.9%. However, the innovative pharmaceutical sector continues to rise, gaining 2.6% [1] - Overall, there has been a significant outflow of funds from the market, with an average daily fund intensity of -9.9 million HKD, compared to +12.6 million HKD the previous week [2] - Earnings per share (EPS) expectations for the Hong Kong stock market have been slightly revised down by 0.1%, indicating a clear divergence among industries, with 11 industries seeing upward revisions and 18 experiencing downward adjustments [3] Summary by Sections Market Performance - The Hang Seng Index closed at 24,508, reflecting a 3.5% decline this week, while the Hang Seng Technology Index decreased by 4.9% [12] - The innovative pharmaceutical sector has shown resilience, with a 2.6% increase, contrasting with significant declines in other sectors such as automotive (-7.9%) and financials (-3.6%) [1][16] Fund Flow - There was a notable outflow of funds across the market, with 26 industries experiencing outflows, particularly in automotive (-2.3 million HKD/day) and non-bank financials (-2.0 million HKD/day) [2] - Only four industries saw inflows, with pharmaceuticals leading at +1.4 million HKD/day [2] Earnings Forecast - The overall EPS forecast for the Hong Kong stock market has been adjusted down by 0.1%, with significant upward revisions in the steel industry (+235.8%) and pharmaceuticals (+1.4%) [3] - Conversely, industries such as basic chemicals (-3.2%) and telecommunications (-0.9%) faced downward revisions [3]